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Abstract 
Introduction: Susceptibility-weighted imaging of the substantia nigra (SN) both at 7 and 3 Tesla (T) 
has shown high accuracy in distinguishing patients with Parkinson’s disease (PD) and healthy 
subjects (HS). Patients with rapid eye movement (REM) behavior disorder (RBD) can develop 
synucleinopathies, and such risk is higher with dopamine transporter single photon emission 
tomography (123I-FP-CIT SPECT) evidence of nigro-striatal dysfunction. We aimed at evaluating 
SN 7T magnetic resonance imaging (7T-MRI) in patients with RBD and determining the agreement 
between MRI and 123I-FP-CIT SPECT. 
Methods: Fifteen patients with idiopathic RBD confirmed by polysomnography and a recent 123I-
FP-CIT SPECT underwent a 7T MR by using three-dimensional gradient-recalled-echo multiecho 
susceptibility-weighted imaging of the SN; the findings were randomly presented with those of 14 
HS and 28 patients with PD and blindly evaluated by an expert neuroradiologist, according to 
recently published criteria. MRI and SPECT results were also compared. 
Results: Nine subjects with RBD had abnormal SPECT; among them, the findings of 7T-MRI were 
rated abnormal in eight. Out of six subjects with RBD with normal SPECT, the 7T-MRI findings of 
five were rated normal. The Cohen’s kappa statistic value of agreement was 0.722.  
Conclusion: Gradient-recalled-echo multiecho susceptibility-weighted imaging of the SN at 7T is 
abnormal in 60% of patients with RBD. The 7T-MRI and 123I-FP-CIT SPECT results showed 
good agreement. 7T-MRI of the SN could represent a safe marker for neurodegenerative disease in 
patients with RBD, however longitudinal study is warranted. 
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Introduction  
Seven Tesla (7T) magnetic resonance imaging (MRI) of the substantia nigra (SN) using high-
resolution three-dimensional susceptibility-weighted imaging (SWI) has been described previously, 
and its pathological correlates are well defined [1,2]. The loss of typical anatomy of the SN, 
particularly the loss of the hyperintense laminar or ovoid-shaped inner components, is reportedly 
able to differentiate patients with Parkinson’s disease (PD) from healthy subjects (HS) with high 
accuracy in both 7T and 3T MRI [3] and a recent meta-analysis of the studies performed both with 
high and ultra-high fields MRI confirmed such results [4]. Furthermore, patients with Multiple 
System Atrophy (MSA), those with Progressive Supranuclear Palsy [4], and some patients with 
Corticobasal Syndrome show a comparable abnormal anatomy of the SN in both 7T and 3T MRI. 
Recently, the abnormal aspect of the SN in susceptibility-weighted imaging has been described in 
asymptomatic carriers of LRRK2 mutations suggesting that such aspect might be an early marker of 
degenerative parkinsonism even before the onset of motor symptoms [5].  
Owing to the physical properties of SWI sequences [6], and partially consistent with pathological 
data [1], the abnormal aspect observed in patients with PD and, presumably, even in patients with 
atypical parkinsonisms is probably due to iron accumulation. 
Idiopathic rapid eye movement (REM) behavior disorder (iRBD) can precede the manifestation of 
neurodegenerative disorders with risk estimates of 17,7% at 5 years, 40,6% at 10 years and 52,4% 
at 12 years [7]. The risk of forthcoming conversion is higher in patients with dopamine transporter 
Single Photon Emission Tomography (123I-FP-CIT SPECT) evidence of nigro-striatal involvement 
and, although with some controversies and lower predictive values, with trans-cranial sonographic 
evidence of SN abnormality [8]. Although not specifically related to the pathogenesis of RBD, both 
methods identify SN abnormalities either directly (Sonography) or indirectly (SPECT) before the 
onset of motor symptoms.  
The description of biomarkers that might detect patients with RBD with high risk of conversion 
could be the first step in selecting subjects in the pre-clinical PD state [9] for neuroprotective drug 
trials.  
We aimed at evaluating the 7T-MRI anatomy of the SN in patients with RBD and determining its 
agreement with 123I-FP-CIT SPECT. 
Methods 
Patients 
We enrolled patients with polysomnography-confirmed iRBD according to International 
Classification of Sleep Disorders 3 diagnostic criteria. We included only those subjects who 
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underwent 123I-FP-CIT SPECT within 3 months of the study, independently from the results of 
such examination. Criteria for exclusion were the presence of a clinical diagnosis of parkinsonism, 
dementia, and the presence of any contraindication to MRI. Patients with a history of head trauma, 
cerebrovascular disease, neurological conditions, other sleep disorders, or current/past treatment 
with a drug known to influence REM sleep were not included. All patients gave their informed 
consent for the enrollment and diagnostic procedures that adhered to an experimental protocol 
named “Seven Tesla MR imaging as preclinical biomarker in populations at risk for Parkinson 
disease” (RF-2013-02354829) approved and funded by Italian Ministry of Health and co-funded by 
Health-Service of Tuscany. The local competent ethics committee approved the study. 
Two movement disorders specialists clinically evaluated (on the same day of the MRI procedure) 
all patients to exclude the diagnosis of parkinsonism. Unified Parkinson’s Disease Rating Scale 
motor item (UPDRSIII) was performed to identify mild motor symptoms. Mini Mental State 
Examination (MMSE) was included in the clinical evaluation. The results of 123I-FP-CIT SCAN 
results were collected.  
MRI protocol and analysis  
All the enrolled patients underwent a 7T-MRI using a GE950MRI scanner (GE Healthcare Medical 
Systems, Milwaukee, WI, USA) equipped with a 2ch-tx/32ch-rx head coil (Nova Medical, 
Wilmington, MA USA). The MRI protocol included three-dimensional (3D) gradient-recalled-echo 
(GRE) multiecho susceptibility-weighted imaging (SWAN; GE Healthcare) sequence targeted to 
the midbrain with the following parameters: covered volume=160×160×21.6 mm3, acquisition 
matrix=320×320×18, eight equally spaced echoes ranging between TE=5.6 ms and TE=41.5 ms, 
TR=55.7 ms, flip angle=8°, NEX=0.7, receiver-bandwidth=50 kHz, scan duration=4 min 2 s. The 
final images were the average of the data from individual echoes, reconstructed with voxel 
size=0.3125×0.3125×1.2 mm3. 
The SN anatomy was evaluated along the rostro-caudal axis at the level of the inferior third of the 
red nucleus (level I), and at the level of the superior cerebellar peduncle decussation (level II) where 
the signal changes are more informative for diagnosing PD [2].  
An expert neuroradiologist (M.C.), blinded to the SPECT results and clinical diagnosis, performed 
the analysis. To guarantee a blind evaluation, the images previously obtained from 28 patients with 
PD [Male/Female (M/F), 17/11; age, 59.1±9.1 years; UPDRSIII score, 17.4±7.2; MMSE score, 
29±1; disease duration, 2.1±1.6 years; values, mean± standard deviation (SD)], and 14 HS healthy 
subjects (M/F, 10/4; age, 57.6±7 years; values, mean±SD) were randomly presented to the 
examiner.  
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The criteria for SN abnormality were the loss of the hyperintense lateral spots at level I or the loss 
of the three-layered organization at level II at least on one side of the midbrain, according to 
previously published criteria [2]. Images were also rated for quality (motion and susceptibility 
artifacts) as either good or poor.  
Statistics 
Contingency tables (Fisher’s exact probability tests) were used to calculate differences in the 
frequencies of categorical variables. 
Between-groups comparison was performed using analysis of variance (ANOVA) test and 
Student’s t-test or Mann Whitney U-test respectively for parametric and non-parametric variables. 
Statistical significance level was set at p<0.05.  
MRI and SPECT results were cross-tabulated for the calculation of agreement and Cohen’s kappa 
statistic (k). Agreement was evaluated as follows: k<0.2= low; k between 0.2 and 0.4=fair; between 
0.41 and 0.61=moderate; k between 0.61 and 0.80=good; and k>0.80=excellent. 
 
Results 
We enrolled 15 patients  (M/F, 12/3; age, 69.3±7.1 years; UPDRSIII score, 3.7±2.2; MMSE score, 
28.8±1.1; disease duration, 6.3±4.1 years; values, mean±SD). Among-groups analysis of patients 
with RBD, PD and HS revealed a significant difference in age (p<0.01), whereas sex frequency did 
not show any significant difference among RBD, PD, and HS (p>0.05). Clinical and demographical 
data of patients with RBD are detailed in Table 1. Nine subjects with RBD showed abnormal 123I-
FP-CIT SPECT findings. Figure 1 shows representative images of a patient with normal 3D GRE 
multiecho susceptibility-weighted imaging MR of the SN at the level of the superior cerebellar 
peduncles decussation (left side) and the inferior third of the red nucleus (right side) showing the 
laminar and ovoidal hyperintensity respectively (Figure 1A) and normal 123I-FP-CIT SPECT 
(Figure 1B). The figure also shows representative images of a patient with RBD showing 
homogeneously hypointense SN in 3D GRE multiecho susceptibility-weighted imaging MR of the 
SN (Figure 1C) and bilateral reduced radiotracer uptake (Figure 1D). 
Regarding image quality analysis, 14 images were rated as good, and one was rated as poor. 
The 7T-MR images from 9 patients with RBD (60%) were rated as “abnormal”. Eight out of nine 
patients with RBD with abnormal MRI showed bilateral abnormal SN. 
The 7T-MR images from 27 subjects with PD and one HS were rated as “abnormal.” Fisher's exact 
test revealed that MRI outcome significantly differed between groups (HS vs. PD p<0.0001; RBD 
vs. HS p=0.0052; RBD vs. PD p=0.0045). 
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The agreement between MRI and SPECT methods was good (k=0.722) when the whole sample was 
considered and excellent (k=0.851) when the analysis was limited to high quality images. 
When comparing patients with RBD with normal MRI and those with abnormal MRI, no 
statistically significant difference emerged in age (p=0.066), sex (p=0.108), RBD duration 
(p=0.573), UPDRSIII score (p=0.491), and MMSE score (p=0.116). 
 
Discussion 
Our data support the involvement of the SN at least in some patients with RBD, revealing that, in 
7T-3D GRE multiecho susceptibility-weighted imaging, the SN has abnormal anatomy in 60% of 
patients with iRBD and without signs of parkinsonism and in 89% of those with RBD with 
evidence of 123I-FP CIT SPECT abnormality.  
Recently, SN abnormality has been reported in 3T-SWI imaging in about 2/3rd of patients with 
RBD not investigated for dopaminergic dysfunction [10]. Moreover, our data are in line with both 
123I-FP-CIT SPECT and sonographic studies showing evidence of nigral and nigro-striatal 
degeneration in at least 60% of patients with RBD [8]. It is reasonable to speculate that the 
abnormal aspect of the SN in patients with RBD is due to an increase in the iron content in the pars 
compacta ventralis. Relaxometry of the SN in RBD population [11] does not support such iron 
content increase; however, the R2* value was measured in the whole SN. Therefore, the difference 
restricted to the pars compacta ventralis could have been missed. It is possible that iRBD population 
includes two different RBD subgroups: one with evidence of SN abnormality and nigro-striatal 
degeneration, and the other with normal anatomy and function of the nigro-striatal pathway thus 
reducing the sensitivity of relaxation measurement in revealing the iron content increase in the 
whole group of RBD patients.  
On the other hand it is possible that RBD with abnormal SN are in a more advanced disease stage, 
albeit our and previous data [8] did not detected disease duration differences between groups with 
normal or abnormal SN or nigro-striatal degeneration. We are aware that the small sample included 
in our study does not allow firm conclusions about the relationship between SN degeneration and 
RBD duration and that the only retrospective collection of data about RBD duration could have 
biased this result. 
Interestingly, although in a premotor state, most (8 out of 9) of subjects with RBD and abnormal 
MRI showed bilateral SN abnormality thus suggesting the development of parkinsonism even in the 
early motor stage. In fact RBD could be the pre-motor phase of MSA or Dementia with Lewy 
Bodies (DLB) other than PD. Atypical parkinsonisms have shown abnormal SN both at 7T and 3T, 
particularly MSA parkinsonism [4]. Longitudinal observation will unveil if patients with abnormal 
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SN will develop parkinsonism or not and if they will develop PD, MSA or DLB.  
The disagreement between SPECT and 7T-MRI in RBD could be related to a suboptimal sensitivity 
and specificity of the MRI of the SN. However, it should be taken into account that, here, the 
patient with normal SPECT and abnormal MRI had an MR image of poor quality, and this could 
have biased the correct reading. Moreover, since the two imaging methods explore different 
components of the nigral neurons, the patient with normal MRI and abnormal SPECT could be 
interpreted according to the recent synaptopathy hypothesis. This hypothesis suggests that the 
neurodegenerative process starts in the dopaminergic synapses in PD and spreads back to the nigral 
neurons [12]. The disagreement between SPECT and 7T-MRI was previously reported and also 
similarly interpreted in asymptomatic LRKK2 carriers [5]. An alternative explanation could be 
related to the accepted view that in the early and premotor phases of PD, dopamine transporter is 
downregulated as a compensatory phenomenon. In such cases, it is reasonable that despite a 
preserved nigral iron content, there could be a functional rearrangement at the synaptic level. 
Similar results indicating a disagreement between the altered presynaptic dopaminergic functional 
marker and the preservation of normal MRI SN aspect have been also reported in patients with PD 
[4].  
The major limitations of this study are the small number of enrolled patients and the lack of a 
longitudinal evaluation of RBD. Moreover, the percentage of patients with RBD with abnormal SN 
could be influenced by a selection bias since the patients with RBD referring to a sleep center 
probably had severe sleep disorder. Moreover the difference in age between patients with RBD and 
patients with PD and HS used to blindly evaluate MRI image, could have biased our results, 
however previous data [2] suggest that SN abnormality in 3D GRE multiecho susceptibility-
weighted imaging is an age-independent phenomen. Furthermore the implementation of the MRI 
protocol with neuromelanin imaging would have provided more information on dopaminergic 
neurons preservation and SN visualization, particularly considering the complex relationship 
between iron and neuromelanin [13]. A longitudinal study involving subjects with RBD is in 
progress; this study aims to establish the role of SN-MRI abnormality in evaluating the risk of 
progression from RBD to the motor phase of synucleinopathy and the mutual relationship of nigral 
anatomical changes with dopamine transporter presynaptic expression. However, the high 
agreement between MRI and SPECT results suggest that 7T-MRI of the SN could represent a non-
invasive tool in the prediction of the highest rate of conversion from RBD to synucleinopathy. We 
believe that the use of SWI-MRI at even lower magnetic field could emerge as a possible marker of 
neurodegeneration in patients with RBD.  
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Figure Caption:  
Figure 1: Example of RBD patients MRI and SPECT results 
MRI and SPECT images of patients with RBD with either normal (A-B) or abnormal findings (C-
D). A, C: 7T 3D GRE multiecho susceptibility-weighted imaging MR of the SN; B, D: 123I-FP-
CIT SPECT. 
MRI, Magnetic Resonance Imaging; SPECT, RBD, REM (Rapid Eye Movement) Behavior 
Disorder; GRE, gradient-recalled-echo; SN: Substantia Nigra; FP-CIT, 
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Table 1: individual clinical, demographic, MRI and SPECT data of RBD patients.    
 A: abnormal, LevI: level I, inferior third of the Red Nucleus; LevII: level II, Superior Cerebellar 
Peduncle Decussation; N: normal; MMSE: Mini Mental State Examination; RBD: REM Behaviour 
Disorder; SPECT: Single Photon Emission Tomography; UPDRS III: Unified Parkinson’s Disease 
Rating Scale motor item 
Age Sex 
RBD Duration 
(ys) UPDRS III MMSE 
MRI 
Quality 
MRI  
Right side 
LevI    LevII 
MRI  
Left side 
LevI    LevII 
MRI 
Diagnosis 
SPECT 
Diagnosis 
71 M 6 4 30 Good A A N A A A 
75 M 2 3 29 Poor A A A A A N 
70 M 4 3 29 Good A A A A A A 
71 M 11 4 27 Good A A A A A A 
69 M 7 0 27 Good A A A A A A 
82 M 15 6 27 Good A A A A A A 
72 M 2 4 29 Good A A N N A A 
66 M 4 5 30 Good A A A A A A 
72 F 10 6 28 Good A A A A A A 
68 M 5 1 29 Good N N N N N N 
68 M 13 3 29 Good N N N N N N 
73 F 3 4 29 Good N N N N N N 
49 M 5 0 30 Good N N N N N N 
71 F 3 7 29 Good N N N N N A 
62 F 4 5 30 Good N N N N N N 
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Highlights: 
• MRI of the substantia nigra is abnormal in a substantial proportion of patients with iRBD despite no signs of parkinsonism 
• MRI of the substantia nigra and 123I-FPCIT-SPECT results are highly consistent 
• Substantia nigra MRI could provide insights about the risk of motor conversion 
